Mario A. Moscarello

Mario A. Moscarello

Auto-generated profile, based on publicly available information

Mario A. Moscarello

The Hospital for Sick Children Research Institute

Research Focus & Metrics

Academic Career Length

59Years (1968-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 September 2006 in Neurochemical Research
Verified
Journal Article
Open access
PDF file
MMMario A. Moscarello
Mario A. Moscarello
FMFabrizio G. Mastronardi
Fabrizio G. Mastronardi
DWD. Denise Wood
D. Denise Wood
The pathogenesis of MS is unknown. In our studies, we have demonstrated an important role for citrullinated myelin basic protein (MBP). The accompanying loss of positive charge compromises the ability of MBP to interact with the lipid bilayer. The conversion of arginine to citrulline in brain is carried out by an enzyme peptidyl arginine deiminase (PAD) 2. The amount of PAD 2 in brain was increased in MS normal-appearing white matter. The mechanism responsible for this increase involved hypomethylation of the promoter region in the PAD 2 gene in MS, but no change (compared to normal) was found in thymus tissue DNA from the same MS patients. In addition, no change was observed in other neurological diseases, including Alzheimer’s, Parkinson’s, and Huntington’s. We propose that citrullinated MBP, resulting from elevated levels of PAD 2 represents an important biochemical pathway in the pathogenesis of MS.

1 July 2003 in Molecular & Cellular Proteomics
Verified
Journal Article
Open access
PDF file
JKJeongkwon Kim
Jeongkwon Kim
FMF. G. Mastronardi
F. G. Mastronardi
DWD. D. Wood
D. D. Wood
DLD. M. Lubman
D. M. Lubman
Ramin ZandRamin Zand
Ramin Zand
MMM. A. Moscarello
M. A. Moscarello
Myelin basic protein (MBP) represents a candidate autoantigen in multiple sclerosis (MS). We isolated MBP from normal and MS human white matter and purified six components (charge isomers) to compare the post-translational modifications on each. The sites and extent of methylation, deimination, and phosphorylation were documented for all tryptic peptides by mass spectrometry. We found that mono and dimethylated arginine 107 was increased in MS samples; deimination of arginine occurred at a number of sites and was elevated in MS; phosphorylation was observed in 10 peptides in normal samples but was greatly reduced or absent in most peptides from MS samples. Data obtained with MBP isolated from fresh brain obtained from a spontaneously demyelinating mouse model supported the view that the changes observed in human brain were probably related to pathogenesis of demyelination, i.e. we found decreased phosphorylation and decreased amounts of glycogen synthesis kinase in brain homogenates using specific antibodies. This study represents the first to define post-translational modifications in demyelinating disease and suggest an important role in pathogenesis.

1 April 2008 in Laboratory Investigation
Verified
Journal Article
Closed access
DWDorothy D Wood
Dorothy D Wood
CACameron A Ackerley
Cameron A Ackerley
BBBen van Den Brand
Ben van Den Brand
LZLi Zhang
Li Zhang
RRReinout Raijmakers
Reinout Raijmakers
MMMario A Moscarello
Mario A Moscarello

20 April 2002 in Journal of Neurochemistry
Verified
Journal Article
Closed access
PDF file
MMM. A. Moscarello
M. A. Moscarello
LPL. Pritzker
L. Pritzker
FMF. G. Mastronardi
F. G. Mastronardi
DWD. D. Wood
D. D. Wood

1 January 2013 in Disease Models & Mechanisms
Verified
Journal Article
Open access
MMMario A. Moscarello
Mario A. Moscarello
HLHelena Lei
Helena Lei
FMFabrizio G. Mastronardi
Fabrizio G. Mastronardi
SWShawn Winer
Shawn Winer
HTHubert Tsui
Hubert Tsui
DWD. Denise Wood
D. Denise Wood
Summary: Multiple sclerosis (MS) is the most common CNS-demyelinating disease of humans, showing clinical and pathological heterogeneity and a general resistance to therapy. We first discovered that abnormal myelin hypercitrullination, even in normal appearing white matter, by peptidylarginine deiminases (PADs) correlates strongly with disease severity and might have an important role in MS progression. Hypercitrullination is known to promote focal demyelination through reduced myelin compaction. Here we report that 2-chloroacetamidine (2CA) a small-molecule, PAD active-site inhibitor, dramatically attenuates disease at any stage in independent neurodegenerative as well as autoimmune MS mouse models. 2CA reduced PAD activity and protein citrullination to pre-disease status. In the autoimmune models, disease induction uniformly induced spontaneous hypercitrullination with citrulline+ epitopes targeted frequently. 2CA rapidly suppressed T cell autoreactivity, clearing brain and spinal cord infiltrates, through selective removal of newly activated T cells. 2CA essentially prevented disease when administered before disease onset or before autoimmune induction, making hypercitrullination and specifically PAD enzymes a therapeutic target in MS models and thus possibly MS.

1 April 2002 in Multiple Sclerosis Journal
Verified
Journal Article
Closed access
MMM A Moscarello
M A Moscarello
BMB Mak
B Mak
TNT A Nguyen
T A Nguyen
DWD D Wood
D D Wood
FMF Mastronardi
F Mastronardi
SLS K Ludwin
S K Ludwin
Treatment with paclitaxel by four intraperitoneal injections (20 mg/kg) 1 week apart attenuated clinical signs in a spontaneously demyelinating model, if given with onset of clinical signs. If given at 2 months of age (1 month prior to clinical signs), disease was almost completely prevented. The astrogliosis, prominent in our model, was reversed by paclitaxel as determined by astrocyte counts and quantitation of GFAP. Electron microscopic examination of affected regions at 2.5 months demonstrated that the myelin was generally normal. By 4 months of age, demyelination was common in the superior cerebellar peduncle, maximal at 6 months, but continued to 8 months. In addition to myelin vacuolation and nude axons, the presence of many thin myelin sheaths suggested remyelination or partial demyelination. Although no evidence of oligodendrocyte loss was seen, nuclear changes were observed. To substantiate that remyelination was occurring, we measured MBP (18.5 kDa), MBP-exon II, Golli-MBP, TP8, Golli-MBP-J37, platelet-derived growth factor a (PDGFRa) and sonic hedgehog (SHH). Of these TP8, PDGFRa and SHH were up-regulated in the untreated transgenic. After paclitaxel treatment, MBP-Exon II, TP8, PDGFRa and SHH were further up-regulated. We concluded that some of the effects of paclitaxel were to stimulate proteins involved in early myelinating events possibly via a signal transduction mechanism.